Molecular Mechanisms of Organelle-based Metabolic Signaling
Molecular Mechanisms of Organelle-based Metabolic Signaling
批准号:
10623647
负责人:
Roberto Zoncu
金额:
$58.76万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-01 至 2028-04-30
关键词:
Cell physiologyCellsCellular MembraneCholesterolCommunicationComplexCyclic AMP-Dependent Protein KinasesCytoplasmDedicationsDiseaseEndoplasmic ReticulumFRAP1 geneFunctional disorderGoalsGrowthGrowth FactorHealthHomeostasisLipidsLysosomesMalignant NeoplasmsMeasuresMediatingMembraneMetabolicMetabolic DiseasesMolecularNeimann-Pick&aposs Disease Type CNerve DegenerationNeurodegenerative DisordersNeuronsNon-Insulin-Dependent Diabetes MellitusNutrientNutrient availabilityOrganellesOrganismOxygenPathogenicityPathway interactionsPhosphotransferasesPhysiologicalProliferatingProtein KinaseRegulationRoleSignal PathwaySignal TransductionSiteSterolsSurfaceTimedetection of nutrientdriving forcehuman diseasenovel therapeutic interventionprogramsrecruitresponsesensor
中文摘要
摘要
英文摘要
ABSTRACT
The molecular mechanisms through which cells sense nutrients remain largely unknown, but their
elucidation is key to our understanding of metabolic regulation both in normal and disease states. At the center
of nutrient sensing and growth regulation is an ancient protein kinase known as the mechanistic Target of
Rapamycin Complex 1 (mTORC1). In response to the combined action of metabolic inputs such as nutrients,
growth factors, energy and oxygen, mTORC1 translocates from the cytoplasm to the surface of lysosomes,
where it becomes activated. Accumulating evidence indicates that aberrant mTORC1 activation at the lysosome
could be a driving force in diseases ranging from cancer to type-2 diabetes to neurodegeneration. Thus, a deep
mechanistic understanding of how mTORC1 is activated and then inactivated in response to nutrients could point
the way to novel therapeutic strategies in these diseases. My lab has made important contributions to the
understanding of mTORC1 pathway organization, and how its function is integrated with the many activities of
the lysosome. In particular, we have identified a dedicated signaling pathway via which cholesterol, an important
building block for cellular membranes, promotes mTORC1 recruitment to the lysosome and activation of its
downstream programs. We have uncovered membrane contact sites between lysosomes and the endoplasmic
reticulum as key nodes where mTORC1 activation by cholesterol occurs, thus implicating inter-organelle
communication as an important aspect of mTORC1 regulation. Furthermore, we found that excess mTORC1
signaling, caused by cholesterol accumulation in the lysosome, drives cellular dysfunction and could be a driving
force in a neurodegenerative and metabolic disease, Niemann-Pick type C (NPC).
These discoveries directly lead to deep questions on the organization of cellular nutrient sensing, which
are at the core of the current MIRA proposal. One key challenge is to elucidate the mechanisms and physiological
roles of lipid-dependent mTORC1 regulation, specifically whether dedicated cholesterol sensors exist in the
lysosomal membrane, and how they couple the abundance of sterol molecules to mTORC1 activation and to
overall metabolic regulation at the cell and organism level. Based on our finding that cholesterol sensing by
mTORC1 involves physical communication between the lysosome and the ER, another major goal of the
proposal is to delineate the machinery that mediates communication and metabolite exchange between the
lysosome and the ER, and how this machinery participates in regulation of mTORC1 as well as another major
metabolic kinase, protein kinase A. Finally, the pathogenic role of dysregulated mTORC1 in NPC, and the ability
of mTORC1 inhibition to restore several parameters of NPC cell function, strongly support mTORC1 as a prime
target in neurodegenerative disease. We will thus determine how lysosomal mTORC1 controls neuronal cell
homeostasis, and how dysregulated mTORC1 signaling contributes to neuronal degeneration. Together, these
studies will shed light on fundamental principles of metabolic organization in health and disease states.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spatio-temporal regulation of mTORC1 signaling in normal and disease states
-
批准号:10408711
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2019
-
负责人:Roberto Zoncu
-
依托单位:
Molecular mechanisms for lipid sensing by mTORC1
-
批准号:10393506
-
项目类别:
-
资助金额:$35.73万
-
财政年份:2019
-
负责人:Roberto Zoncu
-
依托单位:
Spatio-temporal regulation of mTORC1 signaling in normal and disease states
-
批准号:10174962
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2019
-
负责人:Roberto Zoncu
-
依托单位:
ENGINEERING ORGANELLE FUNCTION TO REWIRE CANCER CELL METABOLISM
-
批准号:8756590
-
项目类别:
-
资助金额:$235.38万
-
财政年份:2014
-
负责人:Roberto Zoncu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: